Loading ... Janssen Pharmaceutica and Iktos have partnered to develop applications for small molecule drug discovery using Philips ' AI - based virtual reality technology and Janssen 's expertise in AI - based modelling of small - molecule activities . Meanwhile , Philips will release a beta version of its software as a service ( OS ) platform Makya this year , while Janssen has developed AI - based methods that can replace human models , a move that will speed up drug discoveries .
Janssen Pharmaceutica and Iktos have partnered to develop applications for small molecule drug discovery using Philips ' AI - based virtual reality technology and Janssen 's expertise in AI - based modelling of small - molecule activities . Meanwhile , Philips will release a beta version of its software as a service ( OS ) platform Makya this year , while Janssen has developed AI - based methods that can replace human models , a move that will speed up drug discoveries .